- Home
- Publications
- Publication Search
- Publication Details
Title
Treatment for liver cancer: From sorafenib to natural products
Authors
Keywords
Liver cancer, Natural products, Formation, Therapeutic targets, Structure-activity relationship
Journal
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Volume 224, Issue -, Pages 113690
Publisher
Elsevier BV
Online
2021-07-05
DOI
10.1016/j.ejmech.2021.113690
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Discovery of 4-alkoxy-2-aryl-6,7-dimethoxyquinolines as a new class of topoisomerase I inhibitors endowed with potent in vitro anticancer activity
- (2021) Mostafa M. Elbadawi et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Hepatic Stellate Cell–Macrophage Crosstalk in Liver Fibrosis and Carcinogenesis
- (2020) Michitaka Matsuda et al. SEMINARS IN LIVER DISEASE
- Intra-arterial hepatic beads loaded with irinotecan (DEBIRI) with mFOLFOX6 in unresectable liver metastases from colorectal cancer: a Phase 2 study
- (2020) Simon Pernot et al. BRITISH JOURNAL OF CANCER
- Molecular and cellular basis of the anticancer activity of the prenylated flavonoid icaritin in hepatocellular carcinoma
- (2020) Christian Bailly CHEMICO-BIOLOGICAL INTERACTIONS
- Irinotecan—Still an Important Player in Cancer Chemotherapy: A Comprehensive Overview
- (2020) Mateusz Kciuk et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- 2019 Chinese clinical guidelines for the management of hepatocellular carcinoma: updates and insights
- (2020) Di-Yang Xie et al. Hepatobiliary Surgery and Nutrition
- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Systemic Treatment for Advanced Hepatocellular Carcinoma
- (2019) Mohamed Bouattour et al. Liver Cancer
- Hexokinase-II Inhibition Synergistically Augments the Anti-tumor Efficacy of Sorafenib in Hepatocellular Carcinoma
- (2019) Jeong-Ju Yoo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Integrated analysis of multiple receptor tyrosine kinases identifies Axl as a therapeutic target and mediator of resistance to sorafenib in hepatocellular carcinoma
- (2019) David J. Pinato et al. BRITISH JOURNAL OF CANCER
- First-in-class immune-modulating small molecule Icaritin in advanced hepatocellular carcinoma: preliminary results of safety, durable survival and immune biomarkers
- (2019) Ying Fan et al. BMC CANCER
- Oncofetal HLF transactivates c-Jun to promote hepatocellular carcinoma development and sorafenib resistance
- (2019) Dai-Min Xiang et al. GUT
- p38γ is essential for cell cycle progression and liver tumorigenesis
- (2019) Antonia Tomás-Loba et al. NATURE
- Selective TACE with irinotecan-loaded 40 μm microspheres and FOLFIRI for colorectal liver metastases: phase I dose escalation pharmacokinetic study
- (2019) Toshihiro Tanaka et al. BMC CANCER
- Randomized trials and endpoints in advanced HCC: Role of PFS as a surrogate of survival
- (2019) Josep M. Llovet et al. JOURNAL OF HEPATOLOGY
- Arsenic trioxide inhibits liver cancer stem cells and metastasis by targeting SRF/MCM7 complex
- (2019) Hai-Yang Wang et al. Cell Death & Disease
- HIF-1α-induced RIT1 promotes liver cancer growth and metastasis and its deficiency increases sensitivity to sorafenib
- (2019) Zhen Song et al. CANCER LETTERS
- Berberine attenuates nonalcoholic hepatic steatosis through the AMPK-SREBP-1c-SCD1 pathway
- (2019) Xiaopeng Zhu et al. FREE RADICAL BIOLOGY AND MEDICINE
- Glycyrrhizin Acid and Glycyrrhetinic Acid Modified Polyethyleneimine for Targeted DNA Delivery to Hepatocellular Carcinoma
- (2019) Cao et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Emerging agents and regimens for hepatocellular carcinoma
- (2019) Xiao-Dong Zhu et al. Journal of Hematology & Oncology
- Irinotecan: 25 years of cancer treatment
- (2019) Christian Bailly PHARMACOLOGICAL RESEARCH
- Review about the multi-target profile of resveratrol and its implication in the SGK1 inhibition
- (2019) Giada Catalogna et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Resveratrol alleviates non-alcoholic fatty liver disease through epigenetic modification of the Nrf2 signaling pathway
- (2019) Hossein Hosseini et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- BAP1 mutations define a homogeneous subgroup of hepatocellular carcinoma with fibrolamellar-like features and activated PKA
- (2019) Théo Z. Hirsch et al. JOURNAL OF HEPATOLOGY
- Herbal drug discovery for the treatment of nonalcoholic fatty liver disease
- (2019) Tingting Yan et al. Acta Pharmaceutica Sinica B
- Synergistic anticancer activity of 20(S)-Ginsenoside Rg3 and Sorafenib in hepatocellular carcinoma by modulating PTEN/Akt signaling pathway
- (2018) Mingxia Lu et al. BIOMEDICINE & PHARMACOTHERAPY
- Development of a LC–MS/MS method to investigate the interference of pharmacokinetics of the main constituents in Saxifraga stolonifera : Involvement of drug metabolism enzymes
- (2018) Yuan Wang et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Metabolic disorders across hepatocellular carcinoma in Italy
- (2018) Filomena Morisco et al. LIVER INTERNATIONAL
- Co-delivery doxorubicin and silybin for anti-hepatoma via enhanced oral hepatic-targeted efficiency
- (2018) Ying Li et al. International Journal of Nanomedicine
- Arsenic trioxide reverses the chemoresistance in hepatocellular carcinoma: a targeted intervention of 14–3-3η/NF-κB feedback loop
- (2018) Yongxin Qiu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Irinotecan-Eluting 75–150-μm Embolics Lobar Chemoembolization in Patients with Colorectal Cancer Liver Metastases: A Prospective Single-Center Phase I Study
- (2018) Arash Fereydooni et al. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
- Androgen receptor (AR)/miR-520f-3p/SOX9 signaling is involved in altering hepatocellular carcinoma (HCC) cell sensitivity to the Sorafenib therapy under hypoxia via increasing cancer stem cells phenotype
- (2018) Yao Xiao et al. CANCER LETTERS
- Curcumin Attenuates N-Nitrosodiethylamine-Induced Liver Injury in Mice by Utilizing the Method of Metabonomics
- (2017) Peiyu Qiu et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Arsenic trioxide intravenous infusion combined with transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with pulmonary metastasis: Long-term outcome analysis
- (2017) Hong Tao Hu et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Jordi Bruix et al. LANCET
- Arsenic trioxide is an immune adjuvant in liver cancer treatment
- (2017) Lei Wang et al. MOLECULAR IMMUNOLOGY
- Resveratrol suppresses human hepatocellular carcinoma via targeting HGF-c-Met signaling pathway
- (2017) Feng Gao et al. ONCOLOGY REPORTS
- Phosphoprotein enriched in diabetes (PED/PEA15) promotes migration in hepatocellular carcinoma and confers resistance to sorafenib
- (2017) Cristina Quintavalle et al. Cell Death & Disease
- A Randomized Controlled Trial of Glycyrrhizin Plus Tenofovir vs. Tenofovir in Chronic Hepatitis B with Severe Acute Exacerbation
- (2017) Chao-Hung Hung et al. Clinical and Translational Gastroenterology
- Liver Cancer: Connections with Obesity, Fatty Liver, and Cirrhosis
- (2016) Andrea Marengo et al. Annual Review of Medicine
- Dietary Phytochemicals and Cancer Chemoprevention: A Perspective on Oxidative Stress, Inflammation, and Epigenetics
- (2016) Wenji Li et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Utilization of metabonomics to identify serum biomarkers in murine H22 hepatocarcinoma and deduce antitumor mechanism of Rhizoma Paridis saponins
- (2016) Peiyu Qiu et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Biology, Epidemiology, Clinical Aspects of Hepatocellular Carcinoma and the Role of Sorafenib
- (2016) Gianluigi Mazzoccoli et al. CURRENT DRUG TARGETS
- Glycyrrhetinic Acid and Its Derivatives: Anti-Cancer and Cancer Chemopreventive Properties, Mechanisms of Action and Structure- Cytotoxic Activity Relationship
- (2016) Ali Roohbakhsh et al. CURRENT MEDICINAL CHEMISTRY
- PARAGON II – A single arm multicentre phase II study of neoadjuvant therapy using irinotecan bead in patients with resectable liver metastases from colorectal cancer
- (2016) R.P. Jones et al. EJSO
- Modulatory effects of silibinin in various cell signaling pathways against liver disorders and cancer – A comprehensive review
- (2016) Navaneethakrishnan Polachi et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Silibinin derivatives as anti-prostate cancer agents: Synthesis and cell-based evaluations
- (2016) Bao Vue et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Patient-derived mouse xenografts from pediatric liver cancer predict tumor recurrence and advise clinical management
- (2016) Delphine Nicolle et al. HEPATOLOGY
- Promising new strategies for hepatocellular carcinoma
- (2016) Yasunari Nakamoto HEPATOLOGY RESEARCH
- Tobacco carcinogen induces both lung cancer and non-alcoholic steatohepatitis and hepatocellular carcinomas in ferrets which can be attenuated by lycopene supplementation
- (2016) Koichi Aizawa et al. INTERNATIONAL JOURNAL OF CANCER
- Natural Products as Sources of New Drugs from 1981 to 2014
- (2016) David J. Newman et al. JOURNAL OF NATURAL PRODUCTS
- Glycyrrhetinic Acid Mediated Drug Delivery Carriers for Hepatocellular Carcinoma Therapy
- (2016) Yuee Cai et al. MOLECULAR PHARMACEUTICS
- Prospective Study of Transcatheter Arterial Chemoembolization (TACE) with Ginsenoside Rg3 versus TACE Alone for the Treatment of Patients with Advanced Hepatocellular Carcinoma
- (2016) Bo Zhou et al. RADIOLOGY
- Biological fluorination from the sea: discovery of a SAM-dependent nucleophilic fluorinating enzyme from the marine-derived bacterium Streptomyces xinghaiensis NRRL B24674
- (2016) Long Ma et al. RSC Advances
- Anti-Cancer Properties of the Naturally Occurring Aphrodisiacs: Icariin and Its Derivatives
- (2016) Hui-Li Tan et al. Frontiers in Pharmacology
- Randomized clinical control study of locoregional therapy combined with arsenic trioxide for the treatment of hepatocellular carcinoma
- (2015) Hui Wang et al. CANCER
- Silibinin and STAT3: A natural way of targeting transcription factors for cancer therapy
- (2015) Joaquim Bosch-Barrera et al. CANCER TREATMENT REVIEWS
- Synthesis and cancer cell growth inhibitory activity of icaritin derivatives
- (2015) Chen Wang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Increased incidence of cancer and cancer-related mortality among persons with chronic hepatitis C infection, 2006–2010
- (2015) Robert D. Allison et al. JOURNAL OF HEPATOLOGY
- Resveratrol improves hepatic steatosis by inducing autophagy through the cAMP signaling pathway
- (2015) Yong Zhang et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Efficacy of Berberine in Patients with Non-Alcoholic Fatty Liver Disease
- (2015) Hong-Mei Yan et al. PLoS One
- Identification of a fluorometabolite from Streptomyces sp. MA37: (2R3S4S)-5-fluoro-2,3,4-trihydroxypentanoic acid
- (2015) Long Ma et al. Chemical Science
- Autophagy-induced RelB/p52 activation mediates tumour-associated macrophage repolarisation and suppression of hepatocellular carcinoma by natural compound baicalin
- (2015) H-Y Tan et al. Cell Death & Disease
- A novel anti-cancer agent Icaritin suppresses hepatocellular carcinoma initiation and malignant growth through the IL-6/Jak2/Stat3 pathway
- (2015) Hong Zhao et al. Oncotarget
- Rapid preparation of rare ginsenosides by acid transformation and their structure-activity relationships against cancer cells
- (2015) Kai Quan et al. Scientific Reports
- STAT3 Mediates Regorafenib-Induced Apoptosis in Hepatocellular Carcinoma
- (2014) W.-T. Tai et al. CLINICAL CANCER RESEARCH
- Silybin exerts antioxidant effects and induces mitochondrial biogenesis in liver of rat with secondary biliary cirrhosis
- (2014) Gaetano Serviddio et al. FREE RADICAL BIOLOGY AND MEDICINE
- Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease
- (2014) Forouzan Faghihzadeh et al. NUTRITION RESEARCH
- Vincristine and Irinotecan in Children with Relapsed Hepatoblastoma: A Single-Institution Experience
- (2014) Yu-tong Zhang et al. PEDIATRIC HEMATOLOGY AND ONCOLOGY
- Hepatic Arterial Infusion with Irinotecan in Patients with Liver Metastases of Colorectal Cancer: Results of an Extended Phase I Study
- (2013) K. Eichler et al. CHEMOTHERAPY
- A Phase I Dose-Finding Study of Silybin Phosphatidylcholine (Milk Thistle) in Patients With Advanced Hepatocellular Carcinoma
- (2013) Abby B. Siegel et al. INTEGRATIVE CANCER THERAPIES
- Huaier polysaccharides suppresses hepatocarcinoma MHCC97-H cell metastasis via inactivation of EMT and AEG-1 pathway
- (2013) Jiasheng Zheng et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Genistein inhibits hepatocellular carcinoma cell migration by reversing the epithelial-mesenchymal transition: Partial mediation by the transcription factor NFAT1
- (2013) Weiqi Dai et al. MOLECULAR CARCINOGENESIS
- Anti-Cancer Efficacy of Silybin Derivatives - A Structure-Activity Relationship
- (2013) Chapla Agarwal et al. PLoS One
- Long-term exposure to sorafenib of liver cancer cells induces resistance with epithelial-to-mesenchymal transition, increased invasion and risk of rebound growth
- (2012) Hannah van Malenstein et al. CANCER LETTERS
- Efficacy of irinotecan single drug treatment in children with refractory or recurrent hepatoblastoma – A phase II trial of the childhood liver tumour strategy group (SIOPEL)
- (2012) József Zsíros et al. EUROPEAN JOURNAL OF CANCER
- Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: A randomized controlled trial
- (2012) Carmela Loguercio et al. FREE RADICAL BIOLOGY AND MEDICINE
- In Vivo Evaluation of Silybin Nanosuspensions Targeting Liver
- (2012) Yancai Wang et al. Journal of Biomedical Nanotechnology
- Resveratrol improves intrahepatic endothelial dysfunction and reduces hepatic fibrosis and portal pressure in cirrhotic rats
- (2012) Marco Di Pascoli et al. JOURNAL OF HEPATOLOGY
- Glycyrrhizin in patients who failed previous interferon alpha-based therapies: biochemical and histological effects after 52 weeks
- (2012) M. P. Manns et al. JOURNAL OF VIRAL HEPATITIS
- Sensitization of TRAIL-Induced Cell Death by 20(S)-Ginsenoside Rg3 via CHOP-Mediated DR5 Upregulation in Human Hepatocellular Carcinoma Cells
- (2012) J.-Y. Lee et al. MOLECULAR CANCER THERAPEUTICS
- Anticancer Drugs from Traditional Toxic Chinese Medicines
- (2012) Shuli Man et al. PHYTOTHERAPY RESEARCH
- Phase I Randomized, Double-Blind Pilot Study of Micronized Resveratrol (SRT501) in Patients with Hepatic Metastases--Safety, Pharmacokinetics, and Pharmacodynamics
- (2011) L. M. Howells et al. Cancer Prevention Research
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Molecular Targeted Therapy for Hepatocellular Carcinoma: Bench to Bedside
- (2011) Masatoshi Kudo DIGESTIVE DISEASES
- Natural products: An evolving role in future drug discovery
- (2011) Bhuwan B. Mishra et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- A glycyrrhizin-containing preparation reduces hepatic steatosis induced by hepatitis C virus protein and iron in mice
- (2011) Masaaki Korenaga et al. LIVER INTERNATIONAL
- Baicalein inhibits the migration and invasive properties of human hepatoma cells
- (2011) Yung-Wei Chiu et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- The structure–activity relationships of A-ring-substituted aromathecin topoisomerase I inhibitors strongly support a camptothecin-like binding mode
- (2010) Maris A. Cinelli et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Chemical study and medical application of saponins as anti-cancer agents
- (2010) Shuli Man et al. FITOTERAPIA
- Molecular Classification and Novel Targets in Hepatocellular Carcinoma: Recent Advancements
- (2010) Yujin Hoshida et al. SEMINARS IN LIVER DISEASE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started